WallStSmart

HealthEquity Inc (HQY)vsNational Research Corp (NRC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 873% more annual revenue ($1.36B vs $140.00M). HQY leads profitability with a 17.4% profit margin vs 4.2%. NRC appears more attractively valued with a PEG of 1.32. HQY earns a higher WallStSmart Score of 62/100 (C+).

HQY

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 7.5Value: 6.7Quality: 7.5
Piotroski: 7/9Altman Z: 1.86

NRC

Hold

42

out of 100

Grade: D

Growth: 2.7Profit: 6.0Value: 6.0Quality: 3.0
Piotroski: 3/9Altman Z: 1.32
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HQYUndervalued (+58.5%)

Margin of Safety

+58.5%

Fair Value

$185.20

Current Price

$96.26

$88.94 discount

UndervaluedFair: $185.20Overvalued
NRCUndervalued (+51.3%)

Margin of Safety

+51.3%

Fair Value

$28.23

Current Price

$21.12

$7.11 discount

UndervaluedFair: $28.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HQY1 strengths · Avg: 8.0/10
Operating MarginProfitability
28.4%8/10

Strong operational efficiency at 28.4%

NRC1 strengths · Avg: 10.0/10
Return on EquityProfitability
89.4%10/10

Every $100 of equity generates 89 in profit

Areas to Watch

HQY2 concerns · Avg: 4.0/10
P/E RatioValuation
33.7x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.864/10

Grey zone — moderate risk

NRC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

Market CapQuality
$476.23M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.2%3/10

4.2% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : HQY

The strongest argument for HQY centers on Operating Margin. Profitability is solid with margins at 17.4% and operating margin at 28.4%. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bull Case : NRC

The strongest argument for NRC centers on Return on Equity. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio, Altman Z-Score.

Bear Case : NRC

The primary concerns for NRC are Revenue Growth, Market Cap, Profit Margin. A P/E of 89.7x leaves little room for execution misses. Debt-to-equity of 13.75 is elevated, increasing financial risk.

Key Dynamics to Monitor

HQY profiles as a mature stock while NRC is a value play — different risk/reward profiles.

NRC carries more volatility with a beta of 0.38 — expect wider price swings.

HQY is growing revenue faster at 7.6% — sustainability is the question.

HQY generates stronger free cash flow (135M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (62/100 vs 42/100), backed by strong 17.4% margins. NRC offers better value entry with a 51.3% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

National Research Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

National Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.

Want to dig deeper into these stocks?